K191973

Substantially Equivalent

Lumpipulse G CA19-9-N

Applicant: Fujirebio Dianostics, Inc.
Product code: NIG
Advisory panel: Immunology
Date received: 2019-07-24
Decision date: 2019-10-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Malvern, PA, US

Adverse events under product code NIG

product code NIG

Malfunction: 618
Total: 618

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.